Cargando…

Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease

Alzheimer's disease (AD) is a multifactorial metabolic brain disorder characterized by protein aggregates, synaptic failure, and cognitive impairment. In the AD brain is common to observe the accumulation of senile plaques formed by amyloid-beta (Aβ) peptide and the neurofibrillary tangles comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez, María José, Quintanilla, Rodrigo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637502/ https://www.ncbi.nlm.nih.gov/pubmed/26587016 http://dx.doi.org/10.1155/2015/957248

Ejemplares similares

Thiazolidinediones Promote Axonal Growth through the Activation of the JNK Pathway
por: Quintanilla, Rodrigo A., et al.
Publicado: (2013)

Chemotherapy and Chemoprevention by Thiazolidinediones
por: Fröhlich, Eleonore, et al.
Publicado: (2015)

Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
por: Horita, Shoko, et al.
Publicado: (2015)

Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma
por: Sheu, Meei-Ling, et al.
Publicado: (2022)

Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease
por: Cabezas-Opazo, Fabian A., et al.
Publicado: (2015)

The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease
por: Colca, Jerry R., et al.
Publicado: (2021)

Risk of Fracture with Thiazolidinediones: Disease or Drugs?
por: Bazelier, Marloes T., et al.
Publicado: (2012)

Thiazolidinediones and bone fractures
por: Kaku, Kohei, et al.
Publicado: (2011)

Biological potential of thiazolidinedione derivatives of synthetic origin
por: Sucheta, et al.
Publicado: (2017)

Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
por: Ahn, Chang Ho, et al.
Publicado: (2019)

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
por: Froment, Pascal, et al.
Publicado: (2006)

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
por: Wei, Wei, et al.
Publicado: (2011)

Role of thiazolidinediones, insulin sensitizers, in non‐alcoholic fatty liver disease
por: Chang, Eugene, et al.
Publicado: (2013)

Therapeutic Potential of Thiazolidinedione-8 as an Antibiofilm Agent against Candida albicans
por: Feldman, Mark, et al.
Publicado: (2014)

Redefining the role of thiazolidinediones in the management of type 2 diabetes
por: Barnett, Anthony H
Publicado: (2009)

An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2022)

Thiazolidinediones: the Forgotten Diabetes Medications
por: Lebovitz, Harold E.
Publicado: (2019)

Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
por: Yang, Tianxin, et al.
Publicado: (2008)

Recent Pharmacological Developments on Rhodanines and 2,4-Thiazolidinediones
por: Bhatti, Ravinder Singh, et al.
Publicado: (2013)

Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer
por: Chiu, Melody, et al.
Publicado: (2017)

Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease
por: Villavicencio Tejo, Francisca, et al.
Publicado: (2021)

Thiazolidinediones are partially effective bitter blockers
por: Nguyen, Ha, et al.
Publicado: (2023)

Thiazolidinedione induced thyroid associated orbitopathy
por: Lee, Seongmu, et al.
Publicado: (2007)

PPAR-γ Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors
por: Lichtor, Terry, et al.
Publicado: (2008)

The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy in HIV-Infected Patients
por: Sutinen, Jussi
Publicado: (2009)

Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular Mechanisms
por: Bełtowski, Jerzy, et al.
Publicado: (2013)

Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes
por: Stafford, John M, et al.
Publicado: (2007)

Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
por: Bae, Jaehyun, et al.
Publicado: (2021)

Different sites of actions make different responses to thiazolidinediones between mouse and rat models of fatty liver
por: Ebihara, Chihiro, et al.
Publicado: (2022)

A Thiazolidinedione Improves In Vivo Insulin Action on Skeletal Muscle Glycogen Synthase in Insulin-Resistant Monkeys
por: Ortmeyer, Heidi K., et al.
Publicado: (2000)

Thiazolidinediones and Cardiovascular Risk — A Question of Balance
por: Erdmann, Erland, et al.
Publicado: (2009)

Factors Associated with Results and Conclusions of Trials of Thiazolidinediones
por: Rattinger, Gail, et al.
Publicado: (2009)

Mitochondrial permeability transition pore contributes to mitochondrial dysfunction in fibroblasts of patients with sporadic Alzheimer's disease
por: Pérez, María José, et al.
Publicado: (2018)

Type 2 Diabetes: Uses of thiazolidinediones and insulin
por: T. Bloomgarden, Zachary
Publicado: (2011)

Oldies but Goodies: Thiazolidinedione as an Insulin Sensitizer with Cardioprotection
por: Cho, Eun-Hee
Publicado: (2022)

Does Weight Gain Associated with Thiazolidinedione Use Negatively Affect Cardiometabolic Health?
por: Ko, Ki Dong, et al.
Publicado: (2017)

Clinical Management of Nonalcoholic Steatohepatitis (NASH) With the Use of Thiazolidinediones and the Additive Effect of Thiazolidinediones and a GLP-1 Agonist: Case Series
por: Rojas Ortiz, Valentina, et al.
Publicado: (2021)

Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones
por: Benova, Andrea, et al.
Publicado: (2022)

Correlation between PPARG Pro12Ala Polymorphism and Therapeutic Responses to Thiazolidinediones in Patients with Type 2 Diabetes: A Meta-Analysis
por: Jang, Eun Jeong, et al.
Publicado: (2023)

Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's Disease
por: Pérez, María J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_shk5ud9jn69h6qqufjtapr3vdp